Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    20004787 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Omalizumab to Treat Eosinophilic Gastroenteritis
Condition: Gastroenteritis
Intervention: Drug: Omalizumab
2 Recruiting Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders
Condition: Inflammatory Disorder
Intervention:
3 Recruiting Study of Mast Cell Precursors
Conditions: Normal Physiology;   Systemic Mastocytosis
Intervention:

Indicates status has not been verified in more than two years